NASDAQ:NXGL - Nasdaq - US65344E1073 - Common Stock - Currency: USD
NASDAQ:NXGL (5/8/2025, 4:30:02 PM)
2.605
+0.02 (+0.58%)
The current stock price of NXGL is 2.605 USD. In the past month the price decreased by -1.88%. In the past year, price increased by 18.57%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ALC | ALCON INC | 31.44 | 47.91B | ||
COO | COOPER COS INC/THE | 21.99 | 16.58B | ||
ALGN | ALIGN TECHNOLOGY INC | 19.39 | 13.25B | ||
SOLV | SOLVENTUM CORP | 9.96 | 11.53B | ||
MMSI | MERIT MEDICAL SYSTEMS INC | 26.92 | 5.68B | ||
LNTH | LANTHEUS HOLDINGS INC | 12.15 | 5.51B | ||
BLCO | BAUSCH + LOMB CORP | 23.96 | 4.06B | ||
ICUI | ICU MEDICAL INC | 22.97 | 3.52B | ||
HAE | HAEMONETICS CORP/MASS | 16.08 | 3.42B | ||
XRAY | DENTSPLY SIRONA INC | 9.53 | 3.17B | ||
UFPT | UFP TECHNOLOGIES INC | 27.75 | 1.80B | ||
NEOG | NEOGEN CORP | 15.76 | 1.30B |
NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania and currently employs 19 full-time employees. The company went IPO on 2021-12-22. The company is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The firm operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises CG Converting and Packaging, LLC (CGN), a joint venture with C.G. Laboratories Inc. (CG Labs) used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George.
NEXGEL INC
2150 Cabot Blvd West,, Suite B
Langhorne PENNSYLVANIA US
Employees: 19
Phone: 12157028550
The current stock price of NXGL is 2.605 USD. The price increased by 0.58% in the last trading session.
The exchange symbol of NEXGEL INC is NXGL and it is listed on the Nasdaq exchange.
NXGL stock is listed on the Nasdaq exchange.
7 analysts have analysed NXGL and the average price target is 6.12 USD. This implies a price increase of 134.93% is expected in the next year compared to the current price of 2.605. Check the NEXGEL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
NEXGEL INC (NXGL) has a market capitalization of 19.93M USD. This makes NXGL a Nano Cap stock.
NEXGEL INC (NXGL) currently has 19 employees.
NEXGEL INC (NXGL) has a support level at 2.59 and a resistance level at 2.84. Check the full technical report for a detailed analysis of NXGL support and resistance levels.
The Revenue of NEXGEL INC (NXGL) is expected to grow by 49.28% in the next year. Check the estimates tab for more information on the NXGL EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NXGL does not pay a dividend.
NEXGEL INC (NXGL) will report earnings on 2025-05-19.
NEXGEL INC (NXGL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.5).
The outstanding short interest for NEXGEL INC (NXGL) is 1.59% of its float. Check the ownership tab for more information on the NXGL short interest.
ChartMill assigns a technical rating of 1 / 10 to NXGL. When comparing the yearly performance of all stocks, NXGL turns out to be only a medium performer in the overall market: it outperformed 50.94% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to NXGL. NXGL has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months NXGL reported a non-GAAP Earnings per Share(EPS) of -0.5. The EPS increased by 9.72% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -29.87% | ||
ROE | -57.01% | ||
Debt/Equity | 0.16 |
ChartMill assigns a Buy % Consensus number of 83% to NXGL. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 87.76% and a revenue growth 49.28% for NXGL